DiaSorin S.p.A. (BIT: DIA)

Market Cap	5.56B
Revenue (ttm)	1.18B
Net Income (ttm)	188.85M
Shares Out	53.32M
EPS (ttm)	3.54
PE Ratio	29.46
Forward PE	23.72
Dividend	1.15 (1.10%)
Ex-Dividend Date	n/a

Volume	34,445
Open	104.90
Previous Close	104.35
Day's Range	103.00 - 105.40
52-Week Range	82.72 - 112.35
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2024

About DiaSorin

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1968
• Employees: 3,233
• Stock Exchange: Borsa Italiana
• Ticker Symbol: DIA

Financial Performance

In 2023, DiaSorin's revenue was 1.15 billion, a decrease of -15.64% compared to the previous year's 1.36 billion. Earnings were 159.85 million, a decrease of -33.65%.